Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaos Perakakis

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Diabetes, Obesity & Metabolism|February 7, 2019
Lorcaserin treatment decreases body weight and reduces cardiometabolic risk factors in obese adults: A six-month, randomized, placebo-controlled, double-blind clinical trialDario Tuccinardi, Olivia M Farr, Jagriti Upadhyay, et al.
Molecular and Cellular Endocrinology|February 9, 2018
Mesenchymal stem cell (MSC)-mediated survival of insulin producing pancreatic β-cells during cellular stress involves signalling via Akt and ERK1/2Chune Liu, Weiwei Zhang, Natia Peradze, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 8, 2025
Adrenal Cortical Steroidogenic Enzyme Expression is Associated with Hypertension, Obesity and Corticosteroid Use: A Tissue Microarray Study of Human Adrenal TissueAnna Oppliger, Alexander Kirschfink, Lara Benning, et al.
Metabolism: Clinical and Experimental|September 19, 2017
Pharmacotherapy of type 2 diabetes: An updateJagriti Upadhyay, Stergios A Polyzos, Nikolaos Perakakis, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 1, 2023
Activation of β-adrenergic receptor signaling prevents glucocorticoid-induced obesity and adipose tissue dysfunction in male miceManuel Gado, Annett Heinrich, Denise Wiedersich, et al.
Diabetes, Obesity & Metabolism|October 10, 2023
Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysisNikolaos Perakakis, Stefan R Bornstein, Andreas L Birkenfeld, et al.
The Lancet. Diabetes & Endocrinology|February 3, 2022
Sexual dimorphism in COVID-19: potential clinical and public health implicationsNicole Bechmann, Andreas Barthel, Andreas Schedl, et al.
Iscience|December 11, 2024
Symmetric dimethylguanidino valeric acid, a novel single biomarker of hepatic steatosisRoman N Rodionov, Natalia Jarzebska, Yen Chin Koay, et al.
Metabolism: Clinical and Experimental|February 2, 2020
Sex specific effect of ATPase inhibitory factor 1 on body weight: studies in high fat diet induced obese mice and genetic association studies in humansSo-Young Kwak, InHyeok Chung, Joon Kang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2023
vPIF-1 is an insulin-like antiferroptotic viral peptideAlexia Belavgeni, Francesca Maremonti, Wulf Tonnus, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Diabetes, Obesity & Metabolism|February 7, 2019
Lorcaserin treatment decreases body weight and reduces cardiometabolic risk factors in obese adults: A six-month, randomized, placebo-controlled, double-blind clinical trialDario Tuccinardi, Olivia M Farr, Jagriti Upadhyay, et al.
Molecular and Cellular Endocrinology|February 9, 2018
Mesenchymal stem cell (MSC)-mediated survival of insulin producing pancreatic β-cells during cellular stress involves signalling via Akt and ERK1/2Chune Liu, Weiwei Zhang, Natia Peradze, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 8, 2025
Adrenal Cortical Steroidogenic Enzyme Expression is Associated with Hypertension, Obesity and Corticosteroid Use: A Tissue Microarray Study of Human Adrenal TissueAnna Oppliger, Alexander Kirschfink, Lara Benning, et al.
Metabolism: Clinical and Experimental|September 19, 2017
Pharmacotherapy of type 2 diabetes: An updateJagriti Upadhyay, Stergios A Polyzos, Nikolaos Perakakis, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 1, 2023
Activation of β-adrenergic receptor signaling prevents glucocorticoid-induced obesity and adipose tissue dysfunction in male miceManuel Gado, Annett Heinrich, Denise Wiedersich, et al.
Diabetes, Obesity & Metabolism|October 10, 2023
Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysisNikolaos Perakakis, Stefan R Bornstein, Andreas L Birkenfeld, et al.
The Lancet. Diabetes & Endocrinology|February 3, 2022
Sexual dimorphism in COVID-19: potential clinical and public health implicationsNicole Bechmann, Andreas Barthel, Andreas Schedl, et al.
Iscience|December 11, 2024
Symmetric dimethylguanidino valeric acid, a novel single biomarker of hepatic steatosisRoman N Rodionov, Natalia Jarzebska, Yen Chin Koay, et al.
Metabolism: Clinical and Experimental|February 2, 2020
Sex specific effect of ATPase inhibitory factor 1 on body weight: studies in high fat diet induced obese mice and genetic association studies in humansSo-Young Kwak, InHyeok Chung, Joon Kang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2023
vPIF-1 is an insulin-like antiferroptotic viral peptideAlexia Belavgeni, Francesca Maremonti, Wulf Tonnus, et al.
Pageof 7